{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,13]],"date-time":"2025-10-13T19:54:13Z","timestamp":1760385253296,"version":"3.44.0"},"reference-count":13,"publisher":"Elsevier BV","issue":"1-2","license":[{"start":{"date-parts":[[2013,1,1]],"date-time":"2013-01-01T00:00:00Z","timestamp":1356998400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,1,1]],"date-time":"2013-01-01T00:00:00Z","timestamp":1356998400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Affective Disorders"],"published-print":{"date-parts":[[2013,1]]},"DOI":"10.1016\/j.jad.2012.04.024","type":"journal-article","created":{"date-parts":[[2012,9,21]],"date-time":"2012-09-21T01:45:28Z","timestamp":1348191928000},"page":"171-175","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Characterizing relapse prevention in bipolar disorder with adjunctive ziprasidone: Clinical and methodological implications"],"prefix":"10.1016","volume":"144","author":[{"given":"Charles L.","family":"Bowden","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Onur N.","family":"Karayal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jeffrey H.","family":"Schwartz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Balarama K.","family":"Gundapaneni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cedric","family":"O'Gorman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"year":"1994","series-title":"Diagnostic and Statistical Manual of Mental Disorders","author":"American Psychiatric Association","key":"10.1016\/j.jad.2012.04.024_bib1"},{"issue":"Suppl. 4","key":"10.1016\/j.jad.2012.04.024_bib2","first-page":"1","article-title":"Practice guideline for the treatment of patients with bipolar disorder (revision)","volume":"159","author":"American Psychiatric Association","year":"2002","journal-title":"American Journal of Psychiatry"},{"issue":"Suppl. 3","key":"10.1016\/j.jad.2012.04.024_bib3","first-page":"12","article-title":"Atypical antipsychotic augmentation of mood stabilizer therapy in bipolar disorder","volume":"66","author":"Bowden","year":"2005","journal-title":"Journal of Clinical Psychiatry"},{"issue":"2","key":"10.1016\/j.jad.2012.04.024_bib4","doi-asserted-by":"crossref","first-page":"130","DOI":"10.4088\/JCP.09m05482yel","article-title":"Ziprasidone plus a mood stabilizer in subjects with bipolar I disorder: a 6-month, randomized, placebo-controlled, double-blind trial","volume":"71","author":"Bowden","year":"2010","journal-title":"Journal of Clinical Psychiatry"},{"issue":"8","key":"10.1016\/j.jad.2012.04.024_bib5","doi-asserted-by":"crossref","first-page":"1835","DOI":"10.1185\/03007995.2010.489830","article-title":"Improving the design of maintenance studies for bipolar disorder","volume":"26","author":"Gitlin","year":"2010","journal-title":"Current Medical Research and Opinion"},{"key":"10.1016\/j.jad.2012.04.024_bib6","doi-asserted-by":"crossref","unstructured":"Guy, W., 1976. ECDEU Assessment Manual for Psychopharmacology. US Deptartment of Health, Education and Welfare publication (ADM) 76-338 National Institutes of Mental Health, Rockville, MD.","DOI":"10.1037\/e591322011-001"},{"issue":"4","key":"10.1016\/j.jad.2012.04.024_bib7","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1176\/appi.ajp.160.4.741","article-title":"Ziprasidone in the treatment of acute bipolar mania: a three-week, placebo-controlled, double-blind, randomized trial","volume":"160","author":"Keck","year":"2003","journal-title":"American Journal of Psychiatry"},{"issue":"6","key":"10.1016\/j.jad.2012.04.024_bib8","doi-asserted-by":"crossref","first-page":"844","DOI":"10.4088\/JCP.08m04045","article-title":"Long-term safety and efficacy of ziprasidone in subpopulations of patients with bipolar mania","volume":"70","author":"Keck","year":"2009","journal-title":"Journal of Clinical Psychiatry"},{"issue":"12","key":"10.1016\/j.jad.2012.04.024_bib11","doi-asserted-by":"crossref","first-page":"975","DOI":"10.4088\/JCP.v62n1210","article-title":"Comparative efficacy of typical and atypical antipsychotics as add-on therapy to mood stabilizers in the treatment of acute mania","volume":"62","author":"Miller","year":"2001","journal-title":"Journal of Clinical Psychiatry"},{"key":"10.1016\/j.jad.2012.04.024_bib12","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1192\/bjp.134.4.382","article-title":"A new depression scale designed to be sensitive to change","volume":"134","author":"Montgomery","year":"1979","journal-title":"British Journal of Psychiatry"},{"issue":"4","key":"10.1016\/j.jad.2012.04.024_bib13","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1097\/01.jcp.0000169068.34322.70","article-title":"Ziprasidone in acute bipolar mania: a 21-day randomized, double-blind, placebo-controlled replication trial","volume":"25","author":"Potkin","year":"2005","journal-title":"Journal of Clinical Psychopharmacology"},{"issue":"4","key":"10.1016\/j.jad.2012.04.024_bib15","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1177\/0269881108099418","article-title":"Ziprasidone in the treatment of acute mania: a 12-week, placebo-controlled, haloperidol-referenced study","volume":"24","author":"Vieta","year":"2010","journal-title":"Journal of Psychopharmacology"},{"key":"10.1016\/j.jad.2012.04.024_bib17","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1192\/bjp.133.5.429","article-title":"A rating scale for mania: reliability, validity, and sensitivity","volume":"133","author":"Young","year":"1978","journal-title":"British Journal of Psychiatry"}],"container-title":["Journal of Affective Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165032712002984?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165032712002984?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,28]],"date-time":"2025-09-28T01:10:34Z","timestamp":1759021834000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0165032712002984"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,1]]},"references-count":13,"journal-issue":{"issue":"1-2","published-print":{"date-parts":[[2013,1]]}},"alternative-id":["S0165032712002984"],"URL":"https:\/\/doi.org\/10.1016\/j.jad.2012.04.024","relation":{},"ISSN":["0165-0327"],"issn-type":[{"type":"print","value":"0165-0327"}],"subject":[],"published":{"date-parts":[[2013,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Characterizing relapse prevention in bipolar disorder with adjunctive ziprasidone: Clinical and methodological implications","name":"articletitle","label":"Article Title"},{"value":"Journal of Affective Disorders","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jad.2012.04.024","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2012 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}